Northwest Biotherapeutics NWBO Institutional Ownership

OTC NWBO

$0.15 +0.00 (+0.00%)

At close: Sep 30, 2026 · 4:00 PM EDT

Institutions by Trading Activity

9 Institutions

Increased 3 33.3%

Unchanged 6 66.7%

Reduced 0 0.0%

Ownership Statistics

13F · as of 30 Jun, 2026

Institutional Ownership

0.14%

▲+0.11 pp QoQ

Shares Held by Institutions

2.22Mn

of 1.64Bn outstanding

▲+447.14% QoQ

Shares Outstanding

1.64Bn

1.64Bn held outside 13F filers

Institutional Investors

filed 13F for Jun 2026

▲+1 vs prior quarter

Net Shares Added (QoQ)

+1.82Mn

accumulated since last quarter

Value of Holdings

$333.25K

reported market value

Shares Owned by Institutions

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Institutions

Accumulated Distributed

Latest quarter —

Net over range —

Accumulating quarters —

Ownership Summary

Quarter ending 30 Jun, 2026

Northwest Biotherapeutics Inc (OTC:NWBO) has 9 institutional investors that have filed 13F reports for the period ending June 2026.

Their combined ownership stood at 0.1% of outstanding shares in June 2026, up from 0.0% in March 2026.
They increased total shares held in NWBO by 447.14% quarter over quarter, and investors in Northwest Biotherapeutics increased 28.57% from a year ago.
Of these 9 funds, 3 grew their exposure to Northwest Biotherapeutics, 0 cut back, and 6 maintained positions.
The aggregate institutional position in Northwest Biotherapeutics amounted to 2.22Mn shares as of June 2026, up by 1.82Mn shares quarter on quarter, and up 2.01Mn shares year over year.
As of June 30, 2026, the biggest holder of Northwest Biotherapeutics is COMPASS FINANCIAL MANAGEMENT LLC at 1.22Mn shares, representing 0.07% of shares outstanding.
Leading buyers of Northwest Biotherapeutics shares for the quarter ending June 2026 were COMPASS FINANCIAL MANAGEMENT LLC (1.22Mn), KELLEHER FINANCIAL ADVISORS (600.0K), Strive Financial Group ,LLC (100).
Business Quant data shows the 9 biggest positions in Northwest Biotherapeutics as of June 2026 are held by COMPASS FINANCIAL MANAGEMENT LLC (1.22Mn), KELLEHER FINANCIAL ADVISORS (800.0K), VSM Wealth Advisory, LLC (80.57K), Opus Capital Group, LLC (60.15K), Ethos Financial Group, LLC (39.07K), Williams Jones Wealth Management, LLC. (25.0K), Coston, McIsaac & Partners (1.0K), HANTZ FINANCIAL SERVICES, INC. (250), Strive Financial Group ,LLC (100).

Form 13F Holdings

9 Institutional Holders

Report period 30 Jun, 2026

Total shares held 2.22Mn

Of outstanding 0.14%

#	Institution	CIK	Shares Held	% of Outstanding	Change (QoQ)	Change (%)	Value (USD)
1	COMPASS FINANCIAL MANAGEMENT LLC	0002148724	1,215,500	0.07%	▲1,215,500	0.00%	$227.07K
2	KELLEHER FINANCIAL ADVISORS	0001507971	800,000	0.05%	▲600,000	+300.00%	$149.44K
3	VSM Wealth Advisory, LLC	0002050660	80,574	0.00%	0	0.00%	$15.05K
4	Opus Capital Group, LLC	0001330325	60,150	0.00%	0	0.00%	$11
5	Ethos Financial Group, LLC	0001954242	39,070	0.00%	0	0.00%	$6.33K
6	Williams Jones Wealth Management, LLC.	0001788587	25,000	0.00%	0	0.00%	$4.67K
7	Coston, McIsaac & Partners	0001945037	1,000	0.00%	0	0.00%	$0
8	HANTZ FINANCIAL SERVICES, INC.	0001071061	250	0.00%	0	0.00%	$0
9	Strive Financial Group ,LLC	0002090040	100	0.00%	▲100	0.00%	$19